You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

Screen for hepatitis B virus in all cancer patients starting systemic treatment. Find out more about hepatitis B virus screening and management.

Drug Formulary
About the Drug Formulary Email Drug Formulary Team

What’s New in the Drug Formulary

All new and recently updated drug and regimen monographs, patient information sheets, as well as safety and advice documents are available here.

Drug

Published Date: 18 Dec 2025

Revision Summary:
Patient Info Sheet FR: New information sheet (Nouvelle fiche d'information)
Dec 2025
Drug

Published Date: 18 Dec 2025

Revision Summary:
Patient Info Sheet EN: Updated "Will this treatment interact with other medications or natural health products?" section
Patient Info Sheet FR: Updated/revised patient information sheet (Fiche d'information mise à jour/revisée)
Dec 2025
Drug

Published Date: 17 Dec 2025

Revision Summary:
Patient Info Sheet EN: Updated "Do not do this while on treatment" section
Patient Info Sheet FR: New information sheet (Nouvelle fiche d'information)
Dec 2025
Drug

Published Date: 17 Dec 2025

Revision Summary:
Patient Info Sheet FR: New information sheet (Nouvelle fiche d'information)
Dec 2025
Drug

Published Date: 16 Dec 2025

Revision Summary:
Patient Info Sheet FR: New information sheet (Nouvelle fiche d'information)
Dec 2025
Regimen
Published Date: 12 Dec 2025
Cancer Type:
Hematologic, 
Lymphoma - Hodgkin
Show More Show more tags
, Show Less Show fewer tags
Intent: Curative
Revision Summary:

Regimen Monograph: Updated Rationale/Uses, Supplementary Public Funding, Drug Regimen and Cycle Frequency sections

Dec 2025
Regimen
Published Date: 11 Dec 2025
Cancer Type:
Genitourinary, 
Renal cell / Kidney
Show More Show more tags
, Show Less Show fewer tags
Intent: Palliative
Revision Summary:

Regimen Monograph: Updated Supplementary Public Funding section (everolimus ODB general benefit)

Dec 2025
Regimen
Published Date: 11 Dec 2025
Cancer Type:
Lung, 
Neuroendocrine (Lung)
Show More Show more tags
, Show Less Show fewer tags
Intent: Palliative
Revision Summary:

Regimen Monograph: Updated Supplementary Public Funding section (ODB general benefit)

Dec 2025
Regimen
Published Date: 11 Dec 2025
Cancer Type:
Breast
Show More Show more tags
, Show Less Show fewer tags
Intent: Palliative
Revision Summary:

Regimen Monograph: Updated Supplementary Public Funding section (everolimus ODB general benefit)

Dec 2025
Regimen
Published Date: 11 Dec 2025
Cancer Type:
Gastrointestinal, 
Neuroendocrine (GI)
Show More Show more tags
, Show Less Show fewer tags
Intent: Palliative
Revision Summary:

Regimen Monograph: Updated Supplementary Public Funding section (ODB general benefit), Modified Rationale/uses

Dec 2025
Regimen
Published Date: 11 Dec 2025
Cancer Type:
Genitourinary, 
Renal cell / Kidney
Show More Show more tags
, Show Less Show fewer tags
Intent: Palliative
Revision Summary:

Regimen Monograph: Updated Supplementary Public Funding section (ODB general benefit); Modified Rationale/Uses

Dec 2025
Drug

Published Date: 11 Dec 2025

Revision Summary:
Drug Monograph: Added general statements on hepatitis B screening and monitoring; Updated Supplementary Public Funding section
Dec 2025

Pages